Chromatin/Epigenetics
Read More about this categoryShow Less
Epigenetics
Epigenetics means above genetics. It determines how much and whether a gene is expressed without changing DNA sequences. Epigenetic regulations include, 1. DNA methylation: the addition of methyl group to DNA, converting cytosine to 5-methylcytosine, mostly at CpG sites; 2. Histone modifications: posttranslational modificationEpigeneticss of histone proteins including acetylation, methylation, ubiquitylation, phosphorylation and sumoylation; 3. miRNAs: non-coding microRNA downregulating gene expression; 4. Prions: infectious proteins viewed as epigenetic agents capable of inducing a phenotype without changing the genome.
Research Areas
- Bromodomain(44)
- Aurora Kinase(68)
- DNA Methyltransferase(41)
- HDAC(230)
- Histone Acetyltransferases(90)
- Histone Demethylases(110)
- Histone Methyltransferase(258)
- HIF(118)
- JAK(169)
- MBT Domains
- PARP(147)
- Pim(32)
- Protein Ser/Thr Phosphatases(23)
- RNA Polymerase(4)
- Sirtuin(80)
- Sphingosine Kinase-2(1)
- Polycomb repressive complex(2)
- SUMOylation(3)
- PAD(20)
- Epigenetic Reader Domain(269)
- MicroRNA(29)
- Protein Arginine Deiminase(15)
- Chromodomain(1)
- Citrullination(20)
- DNA/RNA Demethylation(2)
- DNA/RNA Methylation(8)
- Histone Deacetylation(43)
- Histones/Histone Peptides(62)
- PHD Domains(1)
- Tandem Tudor & Tudor-like Domains(1)
- PRMT(2)
- Readers(1)
- Small Interfering RNA (siRNA)(14)
- METTL3(4)
- WDR5(3)
- TET Protein(2)
- HuR(1)
- SF3B1(2)
Products Related to Chromatin/Epigenetics(1791)
- GC79070WWQ-03-012CAS: 3076807-15-0Purity: >98.00%
WWQ-03-012 is a selective DESI2 inhibitor with an IC 50 of 47.3 nM.
- GC79142HA2 peptideCAS: 117138-19-9Purity: >98.00%
HA2 peptide is a potent pH-responsive fusion peptide derived from hemagglutinin ( HA ), corresponding to the N-terminal fusion peptide domain consisting of 23 amino acid residues of HIV-1 gp41 envelope glycoprotein.
- GC79143BRD4-IN-12CAS: 3112325-99-9Purity: >98%
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM.
- GC79150NV914CAS: 2341941-41-9Purity: >98.50%
NV914 is an inhibitor of FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) that inhibits the methyltransferase activity of FTSJ1, induces translational readthrough of premature termination codons, and enables genes carrying nonsense mutations to synthesize full-length proteins.
- GC79155OmvitrastatCAS: 3056105-63-3Purity: >99.50%
Omvitrastat (OP-3136) is an orally active, highly selective inhibitor of KAT6A and KAT6B.
- GC79156SYY-B029-2CAS: 2379410-19-0Purity: >99.50%
SYY-B029-2 is a potent histone acetyltransferase (HAT) inhibitor with an IC 50 of 1.4 nM.
- GC79157KDM4C-IN-2CAS: 23705-85-3Purity: >98.00%
KDM4C-IN-2 is a histone lysine demethylase KDM4C ( JMJD2C ) inhibitor with an IC 50 of 147 μM and a K i of 51 μM.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79063 | TNKS-IN-1 | 59455-93-5 | >99.50% | |
TNKS-IN-1 is a selective and potent tankyrase ( TNKS1 / TNKS2 ) inhibitor with IC 50 values of 7.9 nM and 8.7 nM. | ||||
| GC79070 | WWQ-03-012 | 3076807-15-0 | >98.00% | |
WWQ-03-012 is a selective DESI2 inhibitor with an IC 50 of 47.3 nM. | ||||
| GC79072 | MS6076 | - | >98% | |
MS6076 is a mitochondrial protease ClpP agonist. | ||||
| GC79111 | CK2-TN03 | 313226-24-3 | >98.00% | |
CK2-TN03 is an ATP-competitive casein kinase 2 ( CK2 ) inhibitor, with an IC 50 of 165 nM and a K i of 20 nM. | ||||
| GC79142 | HA2 peptide | 117138-19-9 | >98.00% | |
HA2 peptide is a potent pH-responsive fusion peptide derived from hemagglutinin ( HA ), corresponding to the N-terminal fusion peptide domain consisting of 23 amino acid residues of HIV-1 gp41 envelope glycoprotein. | ||||
| GC79143 | BRD4-IN-12 | 3112325-99-9 | >98% | |
BRD4-IN-12 is a potent and orally active BRD4 inhibitor with an IC 50 of 7.9 nM. | ||||
| GC79144 | MC3817 free base | - | >98% | |
MC3817 free base is a selective DNMT1 inhibitor. | ||||
| GC79145 | MC3817 | - | >99.50% | |
MC3817 is a selective DNMT1 inhibitor. | ||||
| GC79146 | Ischemin | 1357059-00-7 | >99.50% | |
Ischemin is a CBP bromodomain inhibitor that inhibits p53 interaction with CBP and transcriptional activity in cells. | ||||
| GC79147 | HLC40 | - | >99.50% | |
HLC40 is a MLL1 histone methyltransferase inhibitor with an IC 50 of 0.82 μM by binding to WDR5. | ||||
| GC79148 | ZINC13000658 | 1324070-76-9 | >99.50% | |
ZINC13000658 is a METTL inhibitor. | ||||
| GC79149 | WX2-43 | 723754-14-1 | >99.00% | |
WX2-43 is a PRMT5-KLF4 inhibitor ( K d of 11.0 nM). | ||||
| GC79150 | NV914 | 2341941-41-9 | >98.50% | |
NV914 is an inhibitor of FTSJ1 (tryptophan tRNA-specific 2'-O-methyltransferase) that inhibits the methyltransferase activity of FTSJ1, induces translational readthrough of premature termination codons, and enables genes carrying nonsense mutations to synthesize full-length proteins. | ||||
| GC79151 | DLG-41 | - | >98.00% | |
DLG-41 is a GAS41 YEATS domain inhibitor ( IC 50 : 600 nM in AlphaLISA). | ||||
| GC79152 | cis-Revumenib | - | >98.50% | |
cis-Revumenib (cis-SNDX-5613) is an isomer of Revumenib. | ||||
| GC79153 | LS-170 | 3099617-79-2 | >99.50% | |
LS-170 is a YEATS2 YEATS domain inhibitor with an IC 50 of 0.14 μM. | ||||
| GC79154 | BAY-7728 | 2767642-46-4 | >98.50% | |
BAY-7728 is an orally active and selective dual inhibitor of KAT6A ( IC 50 : 45 nM)/ KAT6B ( IC 50 : 95 nM). | ||||
| GC79155 | Omvitrastat | 3056105-63-3 | >99.50% | |
Omvitrastat (OP-3136) is an orally active, highly selective inhibitor of KAT6A and KAT6B. | ||||
| GC79156 | SYY-B029-2 | 2379410-19-0 | >99.50% | |
SYY-B029-2 is a potent histone acetyltransferase (HAT) inhibitor with an IC 50 of 1.4 nM. | ||||
| GC79157 | KDM4C-IN-2 | 23705-85-3 | >98.00% | |
KDM4C-IN-2 is a histone lysine demethylase KDM4C ( JMJD2C ) inhibitor with an IC 50 of 147 μM and a K i of 51 μM. | ||||
| GC79158 | TNG917 | 2923223-81-6 | >98% | |
TNG917 is a potent, selective EHMT1/2 inhibitor with oral activity. | ||||
| GC79159 | EZM8266 | 2140164-84-5 | >98.00% | |
EZM8266 is an orally active and selective G9a ( EHMT2 ) histone methyltransferase inhibitor with a human EHMT2 IC 50 of 1 pM. | ||||
| GC79160 | TNG456 | 2962087-36-9 | >98% | |
TNG456 is an orally active, CNS-penetrant, selective, MTA-cooperative PRMT5 inhibitor. | ||||
| GC79161 | MS2928 | - | >98% | |
MS2928 is a selective SETD8 inhibitor with an IC 50 of 0.14 μM against SETD8 methyltransferase activity. | ||||
